🎁 Giveaway No. 1 is closed. Congratulations to Young, prize delivered! Read the update →

Reefer Madness Watch No. 2: A Cannabis Heart Study That Never Asked Anyone About Cannabis

Reefer Madness Watch No. 2 header: A Cannabis Heart Study That Never Asked Anyone About Cannabis. A tile map of the 13 Western states the study counted as legal, showing 6 with legal recreational sales by 2018 and 7 with none: Idaho, Montana, Wyoming, Utah, Arizona, New Mexico and Hawaii.

REEFER MADNESS WATCH · NO. 2 · NOVEMBER 9, 2026

A Cannabis Heart Study That Never Asked Anyone About Cannabis

And it counted Utah, Idaho and Wyoming as legal.

50M

HOSPITAL DISCHARGES

Zero

PATIENTS ASKED ABOUT USE

7 of 13

“LEGAL” STATES WITH NO LEGAL SALES

2018

WHERE THE DATA ENDS

Last time it was a phone survey dressed up as a stroke warning. This time it is worse. This study did not ask a single patient whether they used cannabis. Not one. It looked at where people lived, decided that region was “legal,” and then blamed legalization for what happened in its hospitals.

And with the federal hemp ban landing December 11, expect to see it quoted. So let’s run it through the same three questions: the design, the number, and the comparison group.

CASE NO. 2

THE HEADLINE

“Study links recreational cannabis legalization to rising heart attack admissions”

News-Medical, October 22, 2026

The study behind it is Slavin and colleagues in BMJ Open: “Cannabis legalisation and cardiovascular hospitalisations in the United States: Nationwide difference-in-differences analysis, 2012-2018.”

WHERE IT WAS PUSHED, AND BY WHOM

Watch “associated with” turn into “landing people in the hospital.”

STEP 1 · THE SOURCE · OCT 22

BMJ Group press office, as run on News-Medical

“Study links recreational cannabis legalization to rising heart attack admissions.” The journal publisher’s own release, reposted on News-Medical under the BMJ Group name, ending on the authors’ call for “a cautious approach to legalization laws.”

What changed: heart failure had the biggest number, but the headline picked heart attacks, the scariest word in cardiology. And the policy advice made it into the release.

STEP 2 · THE WIRE · OCT 23

HealthDay, on U.S. News & World Report

“Study Links Marijuana Legalization To Rise In Heart Hospitalizations,” opening with the line that legalization “may be landing more people in the hospital with heart problems.” HealthDay ran a second version for health professionals on November 4, which was picked up by trade sites like Renal and Urology News.

What changed: a regional trend line became people being landed in the hospital. Yes, this is the same HealthDay wire from No. 3.

STEP 3 · THE PROFESSIONAL PRESS · LATE OCTOBER

Psychiatric News Alert and Cardiovascular Business

The American Psychiatric Association’s news service told its members legalization “may be contributing to a rise in heart attacks.” Cardiovascular Business, a trade site for heart doctors, ran it next to a related piece asking whether cannabis heart risk should be taken more seriously.

Fair note: Psychiatric News also reported that the authors said their results support moving cannabis to Schedule III so it can be studied properly. That part did not travel as far.

THE PUSHBACK · OCT 22 TO 29

The lead author himself, Daybreak Wire, and ACSH

Lead author Samuel Slavin called it a modest relative increase when Gizmodo asked, and added: “For any one person, the associated risk is likely small.” Daybreak Wire did the math from the paper’s own tables. The American Council on Science and Health took the design apart. None of them got anywhere near the reach of the wire story.

THE CONTEXT

This landed October 22, in the window between Congress delaying the hemp ban in September and the new December 11 deadline, while Congress was being lobbied hard on what to do with hemp THC. A study ending with advice for legalization laws was always going to get passed around. The author’s own line, that the risk to any one person is likely small, did not make a single headline in the chain above.

WHAT THEY ACTUALLY DID

THE DATA

The National Inpatient Sample, 2012 to 2018: 50,042,564 hospital discharge records. A discharge is a hospital stay, not a person, so the same patient can show up more than once.

THE “EXPOSURE”

Not cannabis use. Geography. The entire Western region (Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming) was treated as having legal sales starting January 2014.

THE COMPARISON

The West versus regions that had not legalized yet, before and after 2014.

THE RESULTS

Each year of “legal sales” was tied to relative increases of about 3.7% in heart failure admissions, 3.1% in heart attack admissions and 2.3% in atrial fibrillation. Stroke, blood clots and ventricular tachycardia were not statistically significant.

WHY THE HEADLINE IS GARBAGE

1Nobody in this study was asked about cannabis

Zero data on whether any of these patients ever touched it, how much, or how. Every heart attack in the West counts toward “legalization,” including the 80 year old who has never been inside a dispensary in her life. This is not a study of cannabis use. It is a study of a map.

2Seven of the thirteen “legal” states had no legal sales

Arizona, Hawaii, Idaho, Montana, New Mexico, Utah and Wyoming had no legal recreational sales at any point from 2012 to 2018. Arizona, Montana and New Mexico did not even legalize until 2020 or later. Hawaii, Idaho, Utah and Wyoming have never had a single recreational store.

And when the clock started in January 2014, exactly one state in the region had stores open: Colorado. Washington followed that July. Oregon, Alaska, Nevada and California came later, California not until 2018, the final year of the data.

3The data stops in 2018

This is a 2026 headline about hospital stays from eight years ago. Before COVID. Before the THCA flower market existed as we know it. It says nothing about hemp, nothing about THCA, and nothing about today. That will not stop anyone from citing it in a 2026 hemp ban fight.

4The West was already different, and changing

Before legalization, the West actually had lower rates for these diagnoses, then rose faster. Western patients were also younger, more often from higher income ZIP codes, and less often White. Meanwhile smoking, obesity, diabetes, insurance coverage and hospital practices were all shifting across regions during these years, and the study adjusted for only a handful of demographic factors. Any of that can move a regional trend line. None of it is cannabis.

5Small relative bumps, tiny real numbers

About 3% a year, relative, and almost none of the coverage turned that into real admissions. Daybreak Wire did, using the paper’s own tables: roughly 5 extra heart attack admissions and 8 extra heart failure admissions per 100,000 residents in the first year of legal sales. That is per 100,000 people in the whole region, users and non-users alike, and it is their math, not a figure the study reported. A 3% bump on a number they never showed you is not a crisis, it is a press release.

6Half the outcomes came up empty

Six conditions were tested. Three reached significance. Stroke, the same outcome last week’s headlines were screaming about, did not. You will not see that one in the headline either.

7Then they jumped straight to policy

The authors admit “an observational study cannot prove causality.” In the same breath they advise lawmakers to take a “cautious approach to legalization laws.” A study that cannot tell you who used cannabis should not be writing legalization advice.

They never measured cannabis use. They measured a map, and Utah was on it.

CREDIT WHERE IT IS DUE

The method is a real one. Comparing a region before and after a change against regions that did not change is a legitimate way to study policy, and 50 million records is a serious dataset.

They also ran negative controls, conditions that should have nothing to do with cannabis. Kidney stone and opioid related admissions showed no effect, which is a point in the study’s favor.

And the authors have a fair answer on the state problem: lumping non-selling states in with Colorado should make a real effect harder to find, not easier, and by 2018 they say over 98% of Western residents lived in or next to a state with legal sales. That is a reasonable defense. It still does not turn a map into a measure of who actually used cannabis.

The American Council on Science and Health put it best: “Marijuana may be guilty, but this study isn’t enough to convict it.”

THE HONEST TAKEAWAY

This study does not show that cannabis causes heart attacks. It also does not prove legalization is harmless to anyone’s heart.

If you want to know what cannabis does to the heart, you need studies that look at people who actually use it. If you have heart disease, high blood pressure, or a history of heart trouble, tell your doctor what you use and how often.

That is No. 2. Seen a headline that smells like Reefer Madness 2.0? Send it to the r/THCAUsersAndReviews mod mail or drop it in the comments on the sub, and it goes in the queue.

More in the series: No. 1, Fox News Turned a Phone Survey Into a Stroke Scare and No. 3, No, Weed Did Not Send 84% of Teens to the ER.

Checked November 9, 2026. Updated November 10, 2026 to add where the claim was pushed and by whom, and real admission numbers. State sales dates are for adult-use (recreational) retail, not medical programs. Nothing here is medical advice.

Stay Lifted, Stay Learning.

SOURCES

  1. News-Medical, “Study links recreational cannabis legalization to rising heart attack admissions,” October 22, 2026, news-medical.net
  2. Slavin et al., “Cannabis legalisation and cardiovascular hospitalisations in the United States: Nationwide difference-in-differences analysis, 2012-2018,” BMJ Open, 2026 (doi 10.1136/bmjopen-2025-111050)
  3. Josh Bloom, American Council on Science and Health, “Marijuana and heart disease: A troubling study. Or maybe not.” October 29, 2026, acsh.org
  4. Cannabis Business Times, U.S. adult-use cannabis legalization timeline, cannabisbusinesstimes.com
  5. Tax Administrators, “State Taxation and Sales of Recreational Marijuana,” taxadmin.org
  6. AHRQ Healthcare Cost and Utilization Project, National Inpatient Sample overview, hcup-us.ahrq.gov
  7. HealthDay, “Study Links Marijuana Legalization To Rise In Heart Hospitalizations,” October 23, 2026, usnews.com
  8. HealthDay, “Cannabis Legalization Linked to More Heart-Related Hospitalizations,” November 4, 2026, healthday.com
  9. Psychiatric News Alert, “Cannabis Legalization Associated With Increased Cardiovascular Hospitalizations,” alert.psychnews.org
  10. Michael Walter, Cardiovascular Business, “Cannabis legalization linked to more hospitalizations for heart attacks, other cardiovascular issues,” October 27, 2026, cardiovascularbusiness.com
  11. Sara Lindqvist, Daybreak Wire, “Legal Cannabis’ 3.7% Yearly Heart Failure Gap Is About 8 Per 100,000,” October 25, 2026, daybreakwire.com (includes lead author’s comments to Gizmodo)

THCaUsersAndReviews: The Cannabis Codex

Discover more from THCaUsersAndReviews: The Cannabis Codex

Subscribe to get the latest posts sent to your email.

One response to “Reefer Madness Watch No. 2: A Cannabis Heart Study That Never Asked Anyone About Cannabis”

  1. […] going in the series: No. 2, A Cannabis Heart Study That Never Asked Anyone About Cannabis and No. 3, No, Weed Did Not Send 84% of Teens to the […]

Leave a Reply